Abstract
The formation of fibrillar deposits of amyloid β protein (Aβ) in the brain is a pathological hallmark of Alzheimer's disease1,2 (AD). A central question is whether Aβ plays a direct role in the neurodegenerative process in AD (refs. 3,4). The involvement of Aβ in the neurodegenerative process is suggested by the neurotoxicity of the fibrillar form of Aβ in vitro5–11. However, mice transgenic for the Aβ precursor protein that develop amyloid deposits in the brain do not show the degree of neuronal loss or tau phosphorylation found in AD (refs. 12–16). Here we show that microinjection of plaque-equivalent concentrations of fibrillar, but not soluble, Aβ in the aged rhesus monkey cerebral cortex results in profound neuronal loss, tau phosphorylation and microglial proliferation. Fibrillar Aβ at plaque-equivalent concentrations is not toxic in the young adult rhesus brain. Aβ toxicity in vivo is also highly species-specific; toxicity is greater in aged rhesus monkeys than in aged marmoset monkeys, and is not significant in aged rats. These results suggest that Aβ neurotoxicity in vivo is a pathological response of the aging brain, which is most pronounced in higher order primates. Thus, longevity may contribute to the unique susceptibility of humans to Alzheimer's disease by rendering the brain vulnerable to Aβ neurotoxicity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Glenner, G.G. & Wong, C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885–890 (1984).
Masters, C.L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245–4249 (1985).
Yankner, B.A. Mechanisms of Neuronal Degeneration in Alzheimer's Disease. Neuron 16, 921–932 (1996).
Selkoe, D.J. Alzheimer's disease: Gentoypes, phenotypes and treatments. Science 275, 630–631 (1997).
Yankner, B.A., Duffy, L.K. & Kirschner, D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279–282 (1990).
Pike, C.J., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311–314 (1991).
Busciglio, J., Lorenzo, A. & Yankner, B.A. Methodological variables in the assessment of β amyloid neurotoxicity. Neurobiol. Aging 13, 609–612 (1992).
Mattson, M.P., Tomaselli, K.J. & Rydel, R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35–49 (1993).
Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci.. 13, 1676–1687 (1993).
Lorenzo, A. & Yankner, B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243–12247 (1994).
Howlett, D.R. et al. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegen. 4, 23–32 (1995).
Quon, D. et al. Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352, 239–241 (1991).
Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527 (1995).
Hsiao, K. et al. Correlative memory deficits, Abeta elevation and amyloid plaques in transgenic mice. Science 274, 99–102 (1996).
Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 94, 13287–13292 (1997).
Irizarry, M.C. et al. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17, 7053–7059 (1997).
Selkoe, D.J., Abraham, C.R., Podlisny, M.B. & Duffy, L.B. Isolation of low molecular wieght proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 46, 1820–1834 (1986).
Struble, R.G., Price, D.L., Jr., Cork, L.C. & Price, D.L. Senile plaques in cortex of aged normal monkey. Brain Res. 361, 267–275 (1985).
Selkoe, D.J., Bell, D.S., Podlisny, M.B., Price, D.L. & Cork, L.C. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235, 873–877 (1987).
Mandelkov, E.M. et al. Microtubule-associated protein tau, paired helical filaments, and phosphorylation. Ann. NY Acad. Sci. 695, 209–216 (1993).
Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K. & Yankner, B.A. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88, 7247–7251 (1991).
Frautschy, S.A., Baird, A. & Cole, G.M. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA 88, 8362–8366 (1991).
Busciglio, J., Lorenzo, A., Yeh, J. & Yankner, B.A. Beta-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879–888 (1995).
Kowall, N.W., McKee, A.C., Yankner, B.A. & Beal, M.F. In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragment. Neurobiol. Aging 13, 537–542 (1992).
Podlisny, M.B. et al. Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity. Am. J. Path. 142, 17–24 (1993).
May, P.C. et al. Beta-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol. Aging 13, 605–607 (1992).
Walker, L.C., Masters, C., Beyreuther, K. & Price, D.L. Amyloid in the brains of aged normal monkey. Acta Neuropathol. 80, 381–387 (1990).
Bons, N., Mestre, N. & Petter, A. Senile plaques and neurofibrillary changes in the brain of an aged lemurain primate, microcebus murinus. Neurobiol. Aging 13, 99–105 (1991).
Martin, L.J., Pardo, C.A., Cork, L.C. & Price, D.L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358–1381 (1994).
Crook, R. et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature Med. 4, 452–455 (1998).
Wisniewski, K.E., Wisniewski, H.M. & Wen, G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17, 278–282 (1985).
Meda, L. et al. Activation of microglial cells by β-amyloid protein and interferon-β. Nature 374, 647–650 (1995).
Giulian, D. et al. Specific domains of β-amyloid from Alzheimer plague elicit neuron killing in human microglia. J. Neurosci. 16, 6021–6037 (1996).
Weldon, D.T. et al. Fibrillar βamyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo J. Neurosci. 18, 2161–2173 (1998).
Frey, P., Sunderji, S. & Waridel, C. in Alzheimer's Disease: Biology, Diagnosis and Therapeutics (eds. Iqbal, K., Winblad, B., Nishimura, T., Takeda, M. & Wisniewski, H.M.) 447–453 (Wiley and Sons, Chichester, 1997).
Greenberg, S.G. & Davies, P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. U.S.A. 87, 5827–5831 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guela, C., Wu, CK., Saroff, D. et al. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat Med 4, 827–831 (1998). https://doi.org/10.1038/nm0798-827
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0798-827
This article is cited by
-
A nonhuman primate model with Alzheimer’s disease-like pathology induced by hippocampal overexpression of human tau
Alzheimer's Research & Therapy (2024)
-
Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity
Molecular Neurodegeneration (2023)
-
Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer’s disease
Molecular Psychiatry (2023)
-
Novel adult cortical neuron processing and screening method illustrates sex- and age-dependent effects of pharmaceutical compounds
Scientific Reports (2022)
-
Rab35 and glucocorticoids regulate APP and BACE1 trafficking to modulate Aβ production
Cell Death & Disease (2021)